Skip to main navigation Skip to search Skip to main content

Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis

  • Yawara Kawano
  • , Kihyun Kim
  • , Chang Ki Min
  • , Youngil Koh
  • , Kenichi Ishizawa
  • , Sung Hyun Kim
  • , Shigeki Ito
  • , Junji Tanaka
  • , Michihiro Uchiyama
  • , Tadao Ishida
  • , Jin Seok Kim
  • , Philippe Moreau
  • , Thomas Martin
  • , Keisuke Tada
  • , Marie Laure Risse
  • , Kenshi Suzuki
  • Kumamoto University
  • Samsung Medical Center, Sungkyunkwan university
  • Seoul National University
  • Yamagata University
  • Dong-A University
  • Iwate Medical University
  • Tokyo Women's Medical University
  • Japanese Red Cross Society
  • Japanese Red Cross Medical Center
  • Yonsei University
  • CHU de Nantes
  • University of California at San Francisco
  • Sanofi-Aventis

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Isatuximab Plus Carfilzomib and Dexamethasone in East Asian Patients With Relapsed Multiple Myeloma: Updated IKEMA Subgroup Analysis'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology